Stephanie Okey, Director at PTC THERAPEUTICS, INC. (PTCT), sold 5,000 shares at $54.00 ($270K) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market sale of $270k PTCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-03-09 | $401K | — | Filing → |
| CRNX | SELL | 2026-03-04 | $119K | — | Filing → |
| CRNX | SELL | 2024-04-02 | $812K | — | Filing → |